As cell therapies continue to advance, the need for better automated, large-scale manufacturing options increases.

The advancement of cell and gene therapy (CGT) is driven by technological and analytical innovations resulting in faster and improved process development, quality control (QC) and manufacturability.

we hope they will start informing treatment decisions in the not too distant future.” Find out more about single cell end-to-end workflow, read more here ...

The workflow can access the entire genetic diversity ... Berkeley Lights is also tackling emerging applications such as cell therapy manufacturing, agriculture. and synthetic biology to help ...

More information: Frederic St‐Denis‐Bissonnette et al, A clinically relevant large‐scale biomanufacturing workflow to produce ... in the development of cell therapy products in Canada.

“Scientists want to pick the best therapy or combination of therapies to address ... of bridging different cells or separate ...

But there are 10 60 potential molecules in the chemical space that might be a therapy,” Kimberly Powell ... generative AI workflow. The Blueprint pre-optimizes molecules for desired therapeutic ...

In a pioneering study, study, researchers have demonstrated that metformin, a common diabetes drug, can slow the growth of ...

Editas Medicine, Inc. ( NASDAQ: EDIT) Strategic Update Conference Call October 22, 2024 8:00 AM ET ...

【第2集】BBC.The.Cell- 细胞 - 科普类型纪录片(1)（中） 译 BBC.The.Cell- 细胞 - 科普类型纪录片 - BBC.The.Cell- 细胞 - 科普类型纪录片(1)（中） ...